UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase

Donald Liu, Bernadette O Fernandez, Alistair Hamilton, Ninian N Lang, Julie M C Gallagher, David E Newby, Martin Feelisch, Richard B Weller, Donald Liu, Bernadette O Fernandez, Alistair Hamilton, Ninian N Lang, Julie M C Gallagher, David E Newby, Martin Feelisch, Richard B Weller

Abstract

The incidence of hypertension and cardiovascular disease (CVD) correlates with latitude and rises in winter. The molecular basis for this remains obscure. As nitric oxide (NO) metabolites are abundant in human skin, we hypothesized that exposure to UVA may mobilize NO bioactivity into the circulation to exert beneficial cardiovascular effects independently of vitamin D. In 24 healthy volunteers, irradiation of the skin with two standard erythemal doses of UVA lowered blood pressure (BP), with concomitant decreases in circulating nitrate and rises in nitrite concentrations. Unexpectedly, acute dietary intervention aimed at modulating systemic nitrate availability had no effect on UV-induced hemodynamic changes, indicating that cardiovascular effects were not mediated via direct utilization of circulating nitrate. UVA irradiation of the forearm caused increased blood flow independently of NO synthase (NOS) activity, suggesting involvement of pre-formed cutaneous NO stores. Confocal fluorescence microscopy studies of human skin pre-labeled with the NO-imaging probe diaminofluorescein 2 diacetate revealed that UVA-induced NO release occurs in a NOS-independent, dose-dependent manner, with the majority of the light-sensitive NO pool in the upper epidermis. Collectively, our data provide mechanistic insights into an important function of the skin in modulating systemic NO bioavailability, which may account for the latitudinal and seasonal variations of BP and CVD.

References

    1. J Histochem Cytochem. 1979 May;27(5):942-6
    1. Am J Epidemiol. 2000 Sep 15;152(6):558-64
    1. Lancet. 2002 Dec 14;360(9349):1903-13
    1. Br J Nutr. 2005 Oct;94(4):483-92
    1. Nat Chem Biol. 2008 Jul;4(7):411-7
    1. FASEB J. 2002 Nov;16(13):1775-85
    1. Eur J Epidemiol. 2000 Apr;16(4):317-22
    1. Curr Vasc Pharmacol. 2009 Jul;7(3):414-22
    1. Ann Clin Biochem. 2009 May;46(Pt 3):226-30
    1. Br Med J (Clin Res Ed). 1982 Oct 2;285(6346):919-23
    1. Nat Rev Drug Discov. 2008 Feb;7(2):156-67
    1. Nitric Oxide. 2010 Feb 15;22(2):120-35
    1. J Invest Dermatol. 1996 Sep;107(3):327-31
    1. J Invest Dermatol. 2009 Apr;129(4):834-42
    1. J Laser Appl. 1993 Fall;5(2-3):43-60
    1. Mol Nutr Food Res. 2010 Aug;54(8):1148-63
    1. Nat Chem Biol. 2005 Oct;1(5):290-7
    1. Acta Physiol (Oxf). 2007 Sep;191(1):59-66
    1. Free Radic Biol Med. 2005 Mar 1;38(5):606-15
    1. Eur Heart J. 2010 May;31(9):1041-5
    1. Nitric Oxide. 2010 Dec 15;23(4):275-83
    1. Hypertension. 1997 Aug;30(2 Pt 1):150-6
    1. Clin Exp Pharmacol Physiol. 1997 Jun;24(6):418-20
    1. Circ Res. 2009 Nov 6;105(10):1031-40
    1. Free Radic Biol Med. 2002 Dec 1;33(11):1590-6
    1. Lancet. 1990 Mar 31;335(8692):765-74
    1. Br J Dermatol. 2012 Nov;167(5):1124-30
    1. Hypertension. 1995 May;25(5):918-23
    1. Int J Epidemiol. 2013 Oct;42(5):1486-96
    1. J Intern Med. 1999 Dec;246(6):577-86
    1. J Invest Dermatol. 2001 Nov;117(5):1179-85
    1. J Epidemiol Community Health. 1998 Jun;52(6):344-52
    1. Cell Metab. 2011 Feb 2;13(2):149-59
    1. BMJ. 2000 Jan 15;320(7228):176-7
    1. Ann Intern Med. 2010 Mar 2;152(5):307-14
    1. Free Radic Biol Med. 2005 Feb 1;38(3):356-68
    1. Free Radic Biol Med. 2003 Dec 15;35(12):1551-9
    1. Stroke. 2004 Apr;35(4):1024
    1. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):336-41
    1. Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):683-90

Source: PubMed

3
Abonnere